Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza.

Bermejo-Martin JF, Ortiz de Lejarazu R, Pumarola T, Rello J, Almansa R, Ramírez P, Martin-Loeches I, Varillas D, Gallegos MC, Serón C, Micheloud D, Gomez JM, Tenorio-Abreu A, Ramos MJ, Molina ML, Huidobro S, Sanchez E, Gordón M, Fernández V, Del Castillo A, Marcos MA, Villanueva B, López CJ, Rodríguez-Domínguez M, Galan JC, Cantón R, Lietor A, Rojo S, Eiros JM, Hinojosa C, Gonzalez I, Torner N, Banner D, Leon A, Cuesta P, Rowe T, Kelvin DJ.

Crit Care. 2009;13(6):R201. doi: 10.1186/cc8208. Epub 2009 Dec 11.

2.

First evidence of a pro-inflammatory response to severe infection with influenza virus H1N1.

de Castro IF, Guzmán-Fulgencio M, García-Alvarez M, Resino S.

Crit Care. 2010;14(1):115. doi: 10.1186/cc8846. Epub 2010 Feb 11.

3.

Increased Th1, Th17 and pro-fibrotic responses in hepatitis C-infected patients are down-regulated after 12 weeks of treatment with pegylated interferon plus ribavirin.

Jimenez-Sousa MA, Almansa R, de la Fuente C, Caro-Paton A, Ruiz L, Sanchez-Antolín G, Gonzalez JM, Aller R, Alcaide N, Largo P, Resino S, de Lejarazu RO, Bermejo-Martin JF.

Eur Cytokine Netw. 2010 Jun;21(2):84-91. doi: 10.1684/ecn.2010.0191. Epub 2010 May 19.

4.

Direct association between pharyngeal viral secretion and host cytokine response in severe pandemic influenza.

Almansa R, Anton A, Ramirez P, Martin-Loeches I, Banner D, Pumarola T, Xu L, Blanco J, Ran L, Lopez-Campos G, Martin-Sanchez F, Socias L, Loza A, Andaluz D, Maravi E, Gordón M, Gallegos MC, Fernandez V, León C, Merino P, Marcos MA, Gandía F, Bobillo F, Resino S, Eiros JM, Castro C, Mateo P, Gonzalez-Rivera M, Rello J, de Lejarazu RO, Kelvin DJ, Bermejo-Martin JF.

BMC Infect Dis. 2011 Aug 31;11:232. doi: 10.1186/1471-2334-11-232.

5.

Hypercytokinemia and hyperactivation of phospho-p38 mitogen-activated protein kinase in severe human influenza A virus infection.

Lee N, Wong CK, Chan PK, Lun SW, Lui G, Wong B, Hui DS, Lam CW, Cockram CS, Choi KW, Yeung AC, Tang JW, Sung JJ.

Clin Infect Dis. 2007 Sep 15;45(6):723-31. Epub 2007 Aug 8.

PMID:
17712756
6.

Cytokine response patterns in severe pandemic 2009 H1N1 and seasonal influenza among hospitalized adults.

Lee N, Wong CK, Chan PK, Chan MC, Wong RY, Lun SW, Ngai KL, Lui GC, Wong BC, Lee SK, Choi KW, Hui DS.

PLoS One. 2011;6(10):e26050. doi: 10.1371/journal.pone.0026050. Epub 2011 Oct 13.

7.

Clinical aspects and cytokine response in severe H1N1 influenza A virus infection.

Hagau N, Slavcovici A, Gonganau DN, Oltean S, Dirzu DS, Brezoszki ES, Maxim M, Ciuce C, Mlesnite M, Gavrus RL, Laslo C, Hagau R, Petrescu M, Studnicska DM.

Crit Care. 2010;14(6):R203. doi: 10.1186/cc9324. Epub 2010 Nov 9.

8.

Intensive cytokine induction in pandemic H1N1 influenza virus infection accompanied by robust production of IL-10 and IL-6.

Yu X, Zhang X, Zhao B, Wang J, Zhu Z, Teng Z, Shao J, Shen J, Gao Y, Yuan Z, Wu F.

PLoS One. 2011;6(12):e28680. doi: 10.1371/journal.pone.0028680. Epub 2011 Dec 9.

9.

T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.

Pinto RA, Arredondo SM, Bono MR, Gaggero AA, Díaz PV.

Pediatrics. 2006 May;117(5):e878-86. Epub 2006 Apr 17.

PMID:
16618789
10.

Predominance of Th2 cytokines, CXC chemokines and innate immunity mediators at the mucosal level during severe respiratory syncytial virus infection in children.

Bermejo-Martin JF, Garcia-Arevalo MC, De Lejarazu RO, Ardura J, Eiros JM, Alonso A, Matías V, Pino M, Bernardo D, Arranz E, Blanco-Quiros A.

Eur Cytokine Netw. 2007 Sep;18(3):162-7. Epub 2007 Sep 7.

11.

Host adaptive immunity deficiency in severe pandemic influenza.

Bermejo-Martin JF, Martin-Loeches I, Rello J, Antón A, Almansa R, Xu L, Lopez-Campos G, Pumarola T, Ran L, Ramirez P, Banner D, Ng DC, Socias L, Loza A, Andaluz D, Maravi E, Gómez-Sánchez MJ, Gordón M, Gallegos MC, Fernandez V, Aldunate S, León C, Merino P, Blanco J, Martin-Sanchez F, Rico L, Varillas D, Iglesias V, Marcos MÁ, Gandía F, Bobillo F, Nogueira B, Rojo S, Resino S, Castro C, Ortiz de Lejarazu R, Kelvin D.

Crit Care. 2010;14(5):R167. doi: 10.1186/cc9259. Epub 2010 Sep 14.

12.

Cytokine response in pediatric patients with pandemic influenza H1N1 2009 virus infection and pneumonia: comparison with pediatric pneumonia without H1N1 2009 infection.

Kim YH, Kim JE, Hyun MC.

Pediatr Pulmonol. 2011 Dec;46(12):1233-9. doi: 10.1002/ppul.21496. Epub 2011 May 27.

PMID:
21626718
13.

Antibody and inflammatory response-mediated severity of pandemic 2009 (pH1N1) influenza virus.

Tiwari N, Kapoor P, Dhole TN.

J Med Virol. 2014 Jun;86(6):1034-40. doi: 10.1002/jmv.23877. Epub 2014 Feb 20.

PMID:
24615905
14.

Proinflammatory chemokines are major mediators of exuberant immune response associated with Influenza A (H1N1) pdm09 virus infection.

Thomas M, Mani RS, Philip M, Adhikary R, Joshi S, Revadi SS, Buggi S, Desai A, Vasanthapuram R.

J Med Virol. 2017 Aug;89(8):1373-1381. doi: 10.1002/jmv.24781. Epub 2017 Mar 3.

PMID:
28198028
15.

Pregnant women infected with pandemic influenza A(H1N1)pdm09 virus showed differential immune response correlated with disease severity.

Periolo N, Avaro M, Czech A, Russo M, Benedetti E, Pontoriero A, Campos A, Peralta LM, Baumeister E.

J Clin Virol. 2015 Mar;64:52-8. doi: 10.1016/j.jcv.2015.01.009. Epub 2015 Jan 13.

PMID:
25728079
16.

Cytokine and chemokine profiles in lung tissues from fatal cases of 2009 pandemic influenza A (H1N1): role of the host immune response in pathogenesis.

Gao R, Bhatnagar J, Blau DM, Greer P, Rollin DC, Denison AM, Deleon-Carnes M, Shieh WJ, Sambhara S, Tumpey TM, Patel M, Liu L, Paddock C, Drew C, Shu Y, Katz JM, Zaki SR.

Am J Pathol. 2013 Oct;183(4):1258-1268. doi: 10.1016/j.ajpath.2013.06.023. Epub 2013 Aug 11.

PMID:
23938324
17.

Low titers of serum antibodies inhibiting hemagglutination predict fatal fulminant influenza A(H1N1) 2009 infection.

Guihot A, Luyt CE, Parrot A, Rousset D, Cavaillon JM, Boutolleau D, Fitting C, Pajanirassa P, Mallet A, Fartoukh M, Agut H, Musset L, Zoorob R, Kirilovksy A, Combadière B, van der Werf S, Autran B, Carcelain G; FluBAL Study Group.

Am J Respir Crit Care Med. 2014 May 15;189(10):1240-9. doi: 10.1164/rccm.201311-2071OC.

PMID:
24646009
18.

The Serum Profile of Hypercytokinemia Factors Identified in H7N9-Infected Patients can Predict Fatal Outcomes.

Guo J, Huang F, Liu J, Chen Y, Wang W, Cao B, Zou Z, Liu S, Pan J, Bao C, Zeng M, Xiao H, Gao H, Yang S, Zhao Y, Liu Q, Zhou H, Zhu J, Liu X, Liang W, Yang Y, Zheng S, Yang J, Diao H, Su K, Shao L, Cao H, Wu Y, Zhao M, Tan S, Li H, Xu X, Wang C, Zhang J, Wang L, Wang J, Xu J, Li D, Zhong N, Cao X, Gao GF, Li L, Jiang C.

Sci Rep. 2015 Jun 1;5:10942. doi: 10.1038/srep10942. Erratum in: Sci Rep. 2016;6:21230.

19.

Plasma cytokine levels and cytokine gene polymorphisms in Mexican patients during the influenza pandemic A(H1N1)pdm09.

Martinez-Ocaña J, Olivo-Diaz A, Salazar-Dominguez T, Reyes-Gordillo J, Tapia-Aquino C, Martínez-Hernández F, Manjarrez ME, Antonio-Martinez M, Contreras-Molina A, Figueroa-Moreno R, Valdez-Vazquez R, Kawa-Karasik S, Rodríguez-Zulueta P, Flisser A, Maravilla P, Romero-Valdovinos M.

J Clin Virol. 2013 Sep;58(1):108-13. doi: 10.1016/j.jcv.2013.05.013. Epub 2013 Jun 26.

PMID:
23809475
20.

Antiviral role of Toll-like receptors and cytokines against the new 2009 H1N1 virus infection.

Liu Y, Chen H, Sun Y, Chen F.

Mol Biol Rep. 2012 Feb;39(2):1163-72. doi: 10.1007/s11033-011-0846-7. Epub 2011 May 21.

PMID:
21603856

Supplemental Content

Support Center